The evolution of knowledge and the dynamics of an industry network

Journal of Management and Governance

Volumn 1, Issue 2, 1997, Pages 147-175

  Orsenigo, Luigi ^a   Pammolli, Fabio ^b   Riccaboni, Massimo ^c   Bonaccorsi, Andrea ^d   Turchetti, Giuseppe ^c  

^a BOCCONI UNIVERSITY   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c SCUOLA SUPERIORE SANT ANNA   (Italy)

^d UNIVERSITY OF PISA   (Italy)

Author keywords

Biotechnology industry; Network dynamics; Pharmaceutical industry; R D collaborative agreements; Science based industries

Indexed keywords

EID: 0004562774     PISSN: 13853457     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009991701667     Document Type: Article

References (62)

1. Arora, A. & Gambardella, A. (1994). Evaluating Technological Information and Utilizing It. Scientific Knowledge, Technological Capability and External Linkages in Biotechnology. Journal of Economic Behavior and Organization 24: 91-114.
2. Austel, V. & Kutter, E. (1994). Practical Procedures in Drug Design. In Ariëns E. J. (ed.) Drug Design, 1-69. New York: Academic Press.
3. Barbanti, P., Gambardella, A. & Orsenigo, L. (1996). The Evolution of the Forms of Collaboration in Biotechnology. International Journal of Technology Management, forthcoming.
4. Barley, S. R., Freeman, J. & Hybels, R. C. (1992). Strategic Alliances in Commercial Biotechnology. In Nohria N. & Eccles R. G. (eds.) Networks and Organizations, 311-347. Cambridge, MA: Harvard Business School Press.
5. Bioscan. (1988-1993). The Biotechnology Corporate Directory Service, Phoenix, Ar.
6. Bonaccorsi, A. & Pammolli, F. (1995). Evolution and Contracts in the Production of Scientific and Technological Knowledge. EUCompEcs 9: 1-29.
7. Bonaccorsi, A. & Pammolli, F. (1997). Technical Development, Design, and the Division of Innovative Labour. International Journal of Technology Management, Special issue on Structural Change, Institutional Change and Models of Capitalism, forthcoming.
8. Borgatti, S. P. & Everett, M. G. (1992). The Notion of Position in Social Network Analysis. In Marsden, P. (ed.) Sociological Methodology. Oxford: Basil Blackwell.
9. Burt, R. S. (1992). Structural Holes. The Social Structure of Competition. Cambridge, MA: Harvard University Press.
10. David, P. A., Mowery, D. & Steinmuller, W. E. (1992). Analysing the Economic Payoffs from Basic Research. Economics of Innovation and New Technology 2: 73-90.
11. Dosi, G. (1982). Technological Paradigms and Technological Trajectories. A Suggested Interpretation of the Determinants and Directions of Technical Change. Research Policy 11: 147-162.
12. Dosi, G. (1988). Sources, Procedures and Microeconomic Effects of Innovation. Journal of Economic Literature 26: 1120-1171.
13. Dosi, G. & Egidi, M. (1991). Substantive and Procedural Uncertainty. Journal of Evolutionary Economics 1: 145-168.
14. Dosi, G., Marengo, L. & Fagiolo, G. (1996). Learning in Evolutionary Environments. Laxenburg: IIASA, wp 96-124, November.
15. Faust, K. (1988). Comparison of Methods for Positional Analysis: Structural and General Equivalences. Social Networks 10: 313-341.
16. Freeman, L. C. (1979). Centrality in Social Networks: Conceptual Clarifications. Social Networks 1: 215-239.
17. Galembos, L. & Sturchio, J. (1996). The Pharmaceutical Industry in the Twentieth Century: A Reappraisal of the Sources of Innovation. History and Technology 13(2): 83-100.
18. Gambardella, A. (1995). Science and Innovation. The U.S. Pharmaceutical Industry During the 1980s. Cambridge, UK: Cambridge University Press.
19. Granstrand, O., Patel, P. & Pavitt, K. (1997). Multi-technology Corporations: Why They Have 'Distributed' Rather than 'Distinctive Core' Competencies. California Management Review 39(4): 8-25.
20. Harary, F. (1969). Graph Theory. Reading, MA: Addison Wesley.
21. Hartigan, J. (1975). Clustering Algorithms. New York: Wiley.
22. Henderson, R. (1994). The Evolution of Integrative Capabilities: Innovation in Cardiovascular Drug Discovery. Industrial and Corporate Change 3(3): 607-630.
23. Henderson, R., Orsenigo, L. & Pisano, G. (1997). The Pharmaceutical Industry and the Revolution in Molecular Biology: Exploring the Interactions between Scientific, Institutional and Organizational Change. CCC Matrix, mimeo.
24. Joyce, G. F. (1992). Directed Molecular Evolution. Scientific American (267): 90-97.
25. Knoke, D. & Kuklinsky, J. (1982). Network Analysis. Beverly Hills, CA: Sage.
26. Kogut, B., Shan, W. & Walker, G. (1992). The Make-or-cooperate Decision in the Context of an Industry Network. In Nohria N. & Eccles R.G. (eds.) Networks and Organizations, 348-365. Cambridge, MA: Harvard Business School Press.
27. Leustra, J. (1974). Clustering Data Arrays. Operations Research 22: 413-414.
28. Levinthal, D. (1996). Organizations and Capabilities: The Role of Decompositions and Units of Selection, Wharton School, University of Pennsylvania, mimeo.
29. Maddox, J. (1992). Finding Wood Among the Trees. Nature (356): 11.
30. Malerba, F. & Orsenigo, L. (1996). The Dynamics and Evolution of Industries. Industrial and Corporate Change 5(1): 51-88.
31. March, J. G. (1991). Exploration and Exploitation in Organizational Learning. Organization Science 2(1): 71-87.
32. Mizruchi, M. S. (1994). Social Network Analysis. Recent Achievements and Current Controversies. Acta Sociologica 37: 329-343.
33. Nelson, R. R. (1961). Uncertainty, Learning and Economics of Parallel Research and Development Efforts. Review of Economics and Statistics 43: 351-364.
34. Nelson, R. R. (1994). The Coevolution of Technology, Industrial Structure, and Supporting Institutions. Industrial and Corporate Change 3(1): 47-63.
35. Nelson, R. R. & Winter, S. G. (1982). An Evolutionary Theory of Economic Change. Cambridge, MA: Harvard University Press.
36. Orsenigo, L. (1989). The Emergence of Biotechnology. New York: St. Martin Press.
37. Orsenigo, L., Pammolli, F. & Riccaboni, M. (1996). A Model of Network Evolution in Biotechnology, mimeo.
38. Pammolli, F. (1996). Innovazione, concorrenza e strategie di sviluppo nell'industria farmaceutica. Guerini: Milan.
39. Pattison, P. (1993). Algebraic Models for Social Networks. Cambridge: Cambridge University Press.
40. Perutz, M. F. (1992). Protein Structure. New Approaches to Disease and Therapy. Washington DC: Library of Congress.
41. Pisano, G. P. (1990). The R&D Boundaries of the Firm: An Empirical Analysis. Administrative Science Quarterly (35): 153-176.
42. Pisano, G. P. (1991). The Hovernance of Innovation. Vertical Integration and Collaborative Arrangements in the Biotechnology Industry. Research Policy (20): 237-249.
43. Powell, W. W. (1996). Interorganizational Collaboration in the Biotechnology Industry. Journal of Institutional and Theoretical Economics 152(1): 197-215.
44. Powell, W. W. & Brantley, P. (1992). Competitive Cooperation in Commercial Biotechnology: Learning through Networks. In Nohria N. & Eccles R. G. (eds.) Networks and Organizations, 366-394. Cambridge, MA: Harvard Business School Press.
45. Powell, W. W., Doput, K. W. & Smith-Doerr, L. (1996). Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in Biotechnology. Administrative Science Quarterly 41: 116-145.
46. Rosenberg, N. (1976). Perspectives on Technology. Cambridge, UK: Cambridge University Press.
47. Ryan, A., Freeman, J. & Hybels, R. (1995). Biotechnology Firms. In Carroll G. R. & Hannan M.T. (eds.) Organizations in Industry, 332-358. Oxford: Oxford University Press.
48. Sander, C. (1994). Design of Protein Structures: Helix Bundles and Beyond. Trends in Biotechnology 12: 163-167.
49. Schaffner, K. F. (1986). Exemplar Reasoning about Biological Models and Diseases: A Relation between the Philosophy of Medicine and Philosophy of Science. The Journal of Medicine and Philosophy 11: 63-80.
50. Schwartzman, D. (1976). Innovation in the Pharmaceutical Industry. Baltimore: Johns Hopkins University Press.
51. Scott, J. (1991). Social Network Analysis. A Handbook. London: Sage.
52. Simon, H. A. (1969). The Architecture of Complexity. The Sciences of the Artificial. Cambridge, MA: MIT Press.
53. Simon, H. A. (1982). Models of Bounded Rationality II. Cambridge, MA: MIT Press.
54. Spath, H. (1980). Cluster Analysis Algorithms. Chichester: Ellis Horwood.
55. Strohman, R. (1994). Epigenesis: The Missing Beat in Biotechnology?. Bio/Technology 12, February: 156-164.
56. Suitor, J. J., Wellman, B. & Morgan, D. L. (1997). It's About Time: How, Why, and When Networks Change. Social Networks 19: 1-7.
57. Testa, B., Meyer, U. A. (1995). Advances in Drug Research. New York: Academic Press.
58. Vos, R. (1991). Drugs Looking for Diseases. Dordrecht: Kluwer Academic Publishers.
59. Walker, G., Kogut, B. & Shan, W. (1997). Social Capital, Structural Holes and the Formation of an Industry Network. Organization Science 8(2): 109-125.
60. Wasserman, S. & Faust, K. (1994). Social Network Analysis: Methods and Applications. Cambridge, UK: Cambridge University Press.
61. Winter, S. G. (1984). Schumpeterian Competition in Alternative Technological Regimes. Journal of Economic Behavior and Organization: 287-320.
62. Zucker, L.G. & Darby, M. R. (1995). Present at the Revolution: Transformation of Technical Identity for a Large Incumbent Pharmaceutical Firm after the Biotechnological Breakthrough. NBER, wp n. 5243, August, Cambridge, MA.